Doctor

Soon available in Europe after EMA authorisation

Neurotrophic keratitis is a condition described since the beginning of the century and is characterised by a clinical picture common to all diseases that impair the sensory innervation of the cornea, either by acting......

The European registration of a safe and effective drug for the treatment of Acanthamoeba keratitis is getting closer.

A.I.F.A. (Agenzia Italiana del Farmaco) has granted official authorisation to start the phase III clinical trial (ODAK 043/SI) in Italy of the study to evaluate efficacy, safety and tolerability......

  Real-world data from numerous studies show a real difficulty for patients with diabetes in keeping plasma glucose under tight control. Consequently, despite......

An all-Italian study, published in September in the well-known journalPLoS ONE, and conducted by the team of Dr. Giuseppe Maulucci, researcher at the Università Cattolica del Sacro Cuore (Department of......

Antibiotic resistance in the spotlight at SICSSO Congress 2017.

The talk entitled 'Antibiotic therapy in the era of multiresistance', given at the XVI SICSSO Congress by Stefania Stefani, Professor of Microbiology at the Department of Biomedical Sciences and......

Those suffering from EMD know that among the most common symptoms and discomforts are distorted vision and impaired perception of colour vision, which......

In the experience of Dr Andrea Bedei, expert in refractive cataract surgery and head of the Ophthalmology O.U. at the Casa di Cura S. Camillo in Forte dei Marmi.

Dr Andrea Bedei, together with Drs Laura Castellini and Alessia Pietrelli, analysed the implant experience with SIFI's Mini WELL. This intraocular lens exploits multifocality related to the induction of an aberration......

The onset of diabetes mellitus (DM) results in multiple damage to the ocular surface, and there have been many studies published in the last 10 years dealing with the correlation. On the relationship between diabetes......